These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 38399331)
1. Chitosan and Anionic Solubility Enhancer Sulfobutylether-β-Cyclodextrin-Based Nanoparticles as Dexamethasone Ophthalmic Delivery System for Anti-Inflammatory Therapy. Racaniello GF; Balenzano G; Arduino I; Iacobazzi RM; Lopalco A; Lopedota AA; Sigurdsson HH; Denora N Pharmaceutics; 2024 Feb; 16(2):. PubMed ID: 38399331 [TBL] [Abstract][Full Text] [Related]
2. Chitosan/sulfobutylether-β-cyclodextrin based nanoparticles coated with thiolated hyaluronic acid for indomethacin ophthalmic delivery. Ricci F; Racaniello GF; Lopedota A; Laquintana V; Arduino I; Lopalco A; Cutrignelli A; Franco M; Sigurdsson HH; Denora N Int J Pharm; 2022 Jun; 622():121905. PubMed ID: 35697201 [TBL] [Abstract][Full Text] [Related]
3. Preparation and evaluation of naringenin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for ocular drug delivery. Zhang P; Liu X; Hu W; Bai Y; Zhang L Carbohydr Polym; 2016 Sep; 149():224-30. PubMed ID: 27261746 [TBL] [Abstract][Full Text] [Related]
4. Enhanced oral delivery of hesperidin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for augmenting its hypoglycemic activity: in vitro-in vivo assessment study. Elmoghayer ME; Saleh NM; Abu Hashim II Drug Deliv Transl Res; 2024 Apr; 14(4):895-917. PubMed ID: 37843733 [TBL] [Abstract][Full Text] [Related]
5. Development of a Chitosan-based Nanoparticle Formulation for Ophthalmic Delivery of Honokiol. Deng F; Hu W; Chen H; Tang Y; Zhang L Curr Drug Deliv; 2018; 15(4):594-600. PubMed ID: 28425869 [TBL] [Abstract][Full Text] [Related]
6. The potential application of hyaluronic acid coated chitosan nanoparticles in ocular delivery of dexamethasone. Kalam MA Int J Biol Macromol; 2016 Aug; 89():559-68. PubMed ID: 27164496 [TBL] [Abstract][Full Text] [Related]
7. Intranasal delivery of dopamine to the striatum using glycol chitosan/sulfobutylether-β-cyclodextrin based nanoparticles. Di Gioia S; Trapani A; Mandracchia D; De Giglio E; Cometa S; Mangini V; Arnesano F; Belgiovine G; Castellani S; Pace L; Lavecchia MA; Trapani G; Conese M; Puglisi G; Cassano T Eur J Pharm Biopharm; 2015 Aug; 94():180-93. PubMed ID: 26032293 [TBL] [Abstract][Full Text] [Related]
9. Effect of hydroxypropyl-β-cyclodextrin on the ocular bioavailability of dexamethasone from a pH-induced mucoadhesive hydrogel. Kesavan K; Kant S; Singh PN; Pandit JK Curr Eye Res; 2011 Oct; 36(10):918-29. PubMed ID: 21950697 [TBL] [Abstract][Full Text] [Related]
10. Dimethyl-β-cyclodextrin/salazosulfapyridine inclusion complex-loaded chitosan nanoparticles for sustained release. Tang P; Yang H; Tang B; Wu D; Du Q; Xu K; Li H Carbohydr Polym; 2017 Jan; 156():215-222. PubMed ID: 27842816 [TBL] [Abstract][Full Text] [Related]
11. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone. Kalam MA Int J Biol Macromol; 2016 Aug; 89():127-36. PubMed ID: 27126165 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and Characterization of Poly(2-hydroxyethylmethacrylate) Contact Lenses Containing Chitosan Nanoparticles as an Ocular Delivery System for Dexamethasone Sodium Phosphate. Behl G; Iqbal J; O'Reilly NJ; McLoughlin P; Fitzhenry L Pharm Res; 2016 Jul; 33(7):1638-48. PubMed ID: 26964548 [TBL] [Abstract][Full Text] [Related]
13. Sulfobutylether-β-cyclodextrin/chitosan nano- and microparticles and their physicochemical characteristics. Fülöp Z; Saokham P; Loftsson T Int J Pharm; 2014 Sep; 472(1-2):282-7. PubMed ID: 24971695 [TBL] [Abstract][Full Text] [Related]
14. The preparation, characterization, and pharmacokinetic studies of chitosan nanoparticles loaded with paclitaxel/dimethyl-β-cyclodextrin inclusion complexes. Ye YJ; Wang Y; Lou KY; Chen YZ; Chen R; Gao F Int J Nanomedicine; 2015; 10():4309-19. PubMed ID: 26170666 [TBL] [Abstract][Full Text] [Related]
15. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats. Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367 [TBL] [Abstract][Full Text] [Related]
16. Chitosan/Sulfobutylether-β-Cyclodextrin Nanoparticles for Ibrutinib Delivery: A Potential Nanoformulation of Novel Kinase Inhibitor. Zhao L; Tang B; Tang P; Sun Q; Suo Z; Zhang M; Gan N; Yang H; Li H J Pharm Sci; 2020 Feb; 109(2):1136-1144. PubMed ID: 31606544 [TBL] [Abstract][Full Text] [Related]
17. Mesalazine/hydroxypropyl-β-cyclodextrin/chitosan nanoparticles with sustained release and enhanced anti-inflammation activity. Tang P; Sun Q; Zhao L; Pu H; Yang H; Zhang S; Gan R; Gan N; Li H Carbohydr Polym; 2018 Oct; 198():418-425. PubMed ID: 30093018 [TBL] [Abstract][Full Text] [Related]
19. Chloramphenicol/sulfobutyl ether-β-cyclodextrin complexes in an ophthalmic delivery system: prolonged residence time and enhanced bioavailability in the conjunctival sac. Xu Y; Zhang C; Zhu X; Wang X; Wang H; Hu G; Fu Q; He Z Expert Opin Drug Deliv; 2019 Jun; 16(6):657-666. PubMed ID: 31033370 [No Abstract] [Full Text] [Related]
20. Sulfobutylether-β-cyclodextrin: A functional biopolymer for drug delivery applications. Pardeshi CV; Kothawade RV; Markad AR; Pardeshi SR; Kulkarni AD; Chaudhari PJ; Longhi MR; Dhas N; Naik JB; Surana SJ; García MC Carbohydr Polym; 2023 Feb; 301(Pt B):120347. PubMed ID: 36446486 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]